Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
about
Cell cycle related proteins in hyperplasia of usual type in breast specimens of patients with and without breast cancer.Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugsp21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.gef gene expression in MCF-7 breast cancer cells is associated with a better prognosis and induction of apoptosis by p53-mediated signaling pathwaySignificance of Her-2/neu protein over expression in Indian breast cancer patientsTelomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis.Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer.Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.An immunohistochemistry study of tissue bcl-2 expression and its serum levels in breast cancer patients.
P2860
Q30820696-99B6EE8C-8754-45D3-AFA6-9285D9E077D1Q33880170-5B2C53C2-18F6-4A3F-9250-C0738E1D8097Q35586711-AF0A8C4D-D2F6-40D5-8D67-446E775E334AQ35600102-A498E8A2-882F-4B17-8762-6688E42936CDQ36261607-34E4360A-24C2-4CBD-B1F0-381A892B147DQ38362851-DBB986A0-F6A1-432C-8015-EC3BBE038C1EQ40932260-085F83B9-6E34-43B0-A2A5-9278D91C56F8Q43661141-39630D56-27C5-4BFB-A1E6-10598FB6BCCBQ44701875-F2E13442-BC9C-4DD8-A8AB-2B368D9C4237Q46738656-FF54C780-CCCF-432B-9918-D76427DCB468Q52923628-1690652E-CF00-426C-9A6F-467092B3B604Q54495241-0591124A-6F67-4BC9-A5CE-48E12EF7D992
P2860
Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Clinical relevance of immunohi ...... and bcl-2 in breast carcinoma.
@en
type
label
Clinical relevance of immunohi ...... and bcl-2 in breast carcinoma.
@en
prefLabel
Clinical relevance of immunohi ...... and bcl-2 in breast carcinoma.
@en
P2093
P1476
Clinical relevance of immunohi ...... and bcl-2 in breast carcinoma.
@en
P2093
A Bánkfalvi
D Breukelmann
P304
P356
10.1016/S0344-0338(00)80051-5
P577
2000-01-01T00:00:00Z